Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Search

Total 76 results found. Search for [ nppa ]

Results 1-20 of 76
E Kumar Sharma
New Delhi, October 24, 2017
On October 20th the ministry of chemicals and fertilizers issued a press note in what seems an attempt to allay industry fears on the issue of price controls.
E Kumar Sharma
New Delhi, September 1, 2017
An integrated and unified approach in the handling affairs concerning health and medicines in the country, could go a long way in unlocking the huge potential of the industry,says DCGI GN Singh.
Joe C Mathew
New Delhi, August 31, 2017
The Medical Technology Association of India (MTaI), a representative body of the domestic arm of global medical device makers, has asked the drug price regulator National Pharmaceutical Pricing Authority (NPPA) to review its decision to cap the prices of knee implants.
Joe C Mathew
New Delhi, August 22, 2017
NGO Medicines Sans Frontiers had challenged the patent claims of Pfizer, calling it way to gain market monopoly. The MSF has argued that Indian firms can supply the same vaccine for much less.
E Kumar Sharma
New Delhi, August 21, 2017
Certain pharma industry leaders point out that the draft of new pharmaceutical policy has been written in an amateurish manner.
Joe C Mathew
New Delhi, August 18, 2017
NPPA Chairman Bhupendra Singh said that a similar exercise to identify the price patterns prevailing in medical device sector is underway.
Joe C Mathew
New Delhi, August 18, 2017
MTaI argued that knee replacement surgery is not a life-threatening procedure but an elective surgery as the patient is free to choose to go for it or go for alternate therapies.
Joe C Mathew
New Delhi, August 17, 2017
NPPA stated that the decision was taken after it was noticed that orthopedic-knee implants were having unjustified, unreasonable and irrational high trade margins leading to their exorbitant prices.
Anand Kumar Patel
July 14, 2017
For instance, Emcure Pharmaceuticals was offering its drug Temcure 250 mg to an Amritsar-based cancer hospital at just Rs 1,950 while  patients have to pay about nine times more at  Rs 18,647.
Niharika Sharma
New Delhi, June 28, 2017
The world cannot blame you if you have been smitten by the shopping bug ahed of the GST roll out. You must have been getting SMS messages from various brands announcing their special sale offers till June 30. 
Mail Today Bureau
New Delhi, June 28, 2017
Ahead of the GST rollout on July 1, the National Pharmaceutical Pricing Authority (NPPA) on Tuesday announced provisional ceiling prices of 761 medicines which includes a list of antibiotics and drugs for treating cancer, HIV, diabetes.
Reuters
June 19, 2017
In a letter sent to the Indian ambassador to Washington last month, 18 members of Congress said they were "troubled" by the price cap, warning that it could deter firms from launching new medical products in India.
PTI
New Delhi, June 13, 2017
The government has fixed GST rate of 12 per cent on most of the essential drugs as against the current tax incidence of around 9 per cent.
Reuters
New Delhi, June 7, 2017
India's drug-pricing regulator has asked the health ministry to add four more medical devices to a list of products eligible for price controls to reduce costs to patients.
Joe C Mathew
Delhi, Edition:May 21, 2017
The stents that Abbott and Medtronic wanted to discontinue had a price tag of Rs 1,00,000-plus.
Reuters
New Delhi/Mumbai, April 30, 2017
A group of global medical-technology companies plans to tell Indian officials next month that any further price control measures would risk future investments and make them less likely to introduce new products in the country, according to an industry source familiar with the matter.
E. Kumar Sharma
Delhi, Edition:April 23, 2017

The tussle between two ministries is causing unwarranted distraction in the trouble-torn pharma space.

PTI
New Delhi, March 14, 2017
Since inception, the National Pharmaceutical Pricing Authority (NPPA) has issued 1,527 demand notices to companies for overcharging on sales of formulations at prices above the notified ceiling price.
E.Kumar Sharma
March 2, 2017
What is the 'right price' for a medicine? This is a matter of constant debate and the response, as you would expect, pretty much depends on the economic background of the person answering the question.
E Kumar Sharma
February 28, 2017
These include drugs from some of the leading pharmaceutical companies like Sun Pharma, Cipla, Dr Reddy's, Alembic, Abbott Healthcare, GlaxoSmithKline among others.
PAGES 1 OF 4  1234
 By Stories    By Author  
From (yyyy-mm-dd)